BioSpace News Archive

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will deliver a corporate presentation at the upcoming virtual investor conferences below.

First-in-human clinical trial of novel, selective thyroid receptor ß agonist for X-ALD

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that its New Drug Submission for BRUKINSA® for the treatment of patients with Waldenström’s macroglobulinemia has been accepted by Health Canada and granted priority review status.

Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster

Repare Therapeutics Inc. announced that Lloyd M. Segal, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15 at 10:15 a.m.

Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd., announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses

Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood pulping co-products, is seeking regulatory ap

Heat Biologics, Inc. today announced that Jeff Wolf, CEO of Heat Biologics, will participate on a virtual panel, entitled, New Approaches to COVID-19:

Combination of sumatriptan succinate and naproxen sodium in a single tablet